These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 14689352

  • 1. Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programs.
    Scholten JN, Driver CR, Munsiff SS, Kaye K, Rubino MA, Gourevitch MN, Trim C, Amofa J, Seewald R, Highley E, Fujiwara PI.
    Clin Infect Dis; 2003 Dec 15; 37(12):1686-92. PubMed ID: 14689352
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [HIV infection, tuberculosis and tuberculin test in Switzerland. The Swiss HIV Cohort Study].
    Sudre P, Rieder H, Bassetti S, Hirschel BJ, Ledergerber B, Malvy D.
    Schweiz Med Wochenschr; 1996 Nov 23; 126(47):2007-12. PubMed ID: 8984608
    [Abstract] [Full Text] [Related]

  • 4. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM, Serrano J, Caylà JA, Vidal R, Ocaña I, Español T.
    Int J Tuberc Lung Dis; 1998 Feb 23; 2(2):140-6. PubMed ID: 9580481
    [Abstract] [Full Text] [Related]

  • 5. A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.
    Gordin FM, Matts JP, Miller C, Brown LS, Hafner R, John SL, Klein M, Vaughn A, Besch CL, Perez G, Szabo S, El-Sadr W.
    N Engl J Med; 1997 Jul 31; 337(5):315-20. PubMed ID: 9233868
    [Abstract] [Full Text] [Related]

  • 6. Postpartum tuberculosis incidence and mortality among HIV-infected women and their infants in Pune, India, 2002-2005.
    Gupta A, Nayak U, Ram M, Bhosale R, Patil S, Basavraj A, Kakrani A, Philip S, Desai D, Sastry J, Bollinger RC, Byramjee Jeejeebhoy Medical College-Johns Hopkins University Study Group.
    Clin Infect Dis; 2007 Jul 15; 45(2):241-9. PubMed ID: 17578786
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
    Casado JL, Moreno S, Fortún J, Antela A, Quereda C, Navas E, Moreno A, Dronda F.
    Clin Infect Dis; 2002 Feb 01; 34(3):386-9. PubMed ID: 11753825
    [Abstract] [Full Text] [Related]

  • 8. Completion of isoniazid preventive therapy and survival in HIV-infected, TST-positive adults in Tanzania.
    Kabali C, von Reyn CF, Brooks DR, Waddell R, Mtei L, Bakari M, Matee M, Pallangyo K, Arbeit RD, Horsburgh CR.
    Int J Tuberc Lung Dis; 2011 Nov 01; 15(11):1515-21, i. PubMed ID: 22008766
    [Abstract] [Full Text] [Related]

  • 9. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
    Moreno S, Miralles P, Diaz MD, Baraia J, Padilla B, Berenguer J, Alberdi JC.
    Arch Intern Med; 2011 Nov 01; 157(15):1729-34. PubMed ID: 9250234
    [Abstract] [Full Text] [Related]

  • 10. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J, Munsiff SS, Driver CR, Sackoff J.
    Clin Infect Dis; 2005 Jul 01; 41(1):83-91. PubMed ID: 15937767
    [Abstract] [Full Text] [Related]

  • 11. Missed opportunities for prevention of tuberculosis among persons with HIV infection--selected locations, United States, 1996-1997.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2000 Aug 04; 49(30):685-7. PubMed ID: 10947056
    [Abstract] [Full Text] [Related]

  • 12. Yield of tuberculin screening among injection drug users.
    Brassard P, Bruneau J, Schwartzman K, Sénécal M, Menzies D.
    Int J Tuberc Lung Dis; 2004 Aug 04; 8(8):988-93. PubMed ID: 15305482
    [Abstract] [Full Text] [Related]

  • 13. Isoniazid TB prophylaxis effective in drug users with HIV.
    J Int Assoc Physicians AIDS Care; 1996 Jun 04; 2(6):51. PubMed ID: 11363698
    [Abstract] [Full Text] [Related]

  • 14. Mycobacterium tuberculosis and human immunodeficiency virus co-infection in intravenous drug users on admission to prison.
    Martín V, Caylà JA, Bolea A, Castilla J.
    Int J Tuberc Lung Dis; 2000 Jan 04; 4(1):41-6. PubMed ID: 10654643
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control.
    Cohn DL.
    Clin Infect Dis; 2000 Jul 04; 31(1):120-4. PubMed ID: 10913407
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
    Liang SH, Lo YC, Lin HH, Chang SY, Chen MY, Hsieh SM, Sheng WH, Sun HY, Hung CC, Chang SC.
    J Microbiol Immunol Infect; 2008 Jun 04; 41(3):200-8. PubMed ID: 18629414
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.